Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Healthy Volunteer
Researchers are investigating how probiotics that increase butyrate production can improve gut health and balance the microbiota. Butyrate is a key short-chain fatty acid that supports intestinal cells, strengthens the gut barrier, and reduces inflammation. The study focuses on adults aged 20 to 80 years and explores the link between butyrate production and beneficial effects on digestion, immunity, and overall wellness. The study involves isolating and identifying probiotic bacterial strains from stool samples that are known to produce or stimulate butyrate production. This observational research will monitor these strains over up to three years to understand how they interact with the microbiota and the host. No specific treatments or interventions are administered, as this is a study of natural bacterial populations. Participants will provide stool samples for bacterial analysis using gene sequencing methods. Researchers will measure the number of butyrate-producing strains present and evaluate their potential benefits. The study also tracks participants health, diet, and lifestyle factors such as exercise and body mass index. The goal is to develop probiotic products based on these findings to support gut health.
Actively Recruiting
Healthy Volunteer
Researchers are studying how to improve the nutrition of babies born by cesarean section by developing a special infant formula. This formula aims to support healthy gut bacteria colonization and better immune and physiological development, addressing the altered microbiota transfer that can occur with cesarean births. The research focuses on infants born vaginally to breastfeeding mothers and seeks to reduce short- and long-term health issues linked to cesarean delivery. The study involves isolating beneficial probiotics from breast milk and stool samples of mothers and babies born vaginally. These probiotics, along with bioactive lipids such as docosahexaenoic acid DHA and alkylglycerols naturally found in breast milk, will be used to create an improved infant formula tailored for cesarean-born infants. The formula will be evaluated preclinically for its potential benefits in a cesarean birth model. Participants include breastfeeding mothers aged 18 years and older and their vaginally born babies under 6 months who are exclusively breastfed. Researchers will collect breast milk and stool samples to assess probiotic viability and bioactive lipid levels in the formula over up to three years. The study will monitor the safety and effects of the formula to help develop personalized nutrition strategies for this population, with the study expected to conclude by September 2028.